Skip to main content
Erschienen in: World Journal of Surgery 4/2017

10.11.2016 | Original Scientific Report

Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?

verfasst von: Theresia Weber, Martin Gottstein, Sabrina Schwenzer, Ambros Beer, Markus Luster

Erschienen in: World Journal of Surgery | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with primary hyperparathyroidism (pHPT) and a negative preoperative Tc-99 sestamibi (MIBI) scintigraphy are considered to have a higher risk of persistent disease. The aim of this study was to assess whether additional imaging with C-11 methionine positron emission tomography/computed tomography (Met-PET/CT) is able to localise sestamibi-negative hyperfunctioning parathyroid glands.

Methods

In 50 patients (38 females, 12 males, age 13–81 years) with pHPT and negative localisation procedures such as ultrasound and sestamibi, a Met-PET/CT was performed before parathyroid surgery. The results of Met-PET/CT were analysed prospectively and compared with intraoperative and histopathological findings. 22% of the patients underwent previous parathyroid and/or thyroid surgery.

Results

Met-PET/CT correctly located a single-gland adenoma in 33 of 45 (73%) patients with pHPT. In 5 patients with multiglandular disease, Met-PET/CT detected at least one hyperfunctional parathyroid gland in 4 patients (80%). In 3 patients with double adenomas, 5 of 6 parathyroids were correctly located. Overall, 40 of 57 (70%) hyperfunctioning glands were identified with Met-PET/CT. Met-PET/CT was false-negative in 12 of 50 (24%) patients and false-positive in only one case (2%). Postoperatively, 48 of 50 patients (96%) were cured.

Conclusions

Additional pre-interventional imaging with Met-PET/CT was able to identify hyperfunctioning parathyroid glands in 74% of patients with pHPT and negative sestamibi scans, thus enabling successful parathyroid surgery.
Literatur
1.
Zurück zum Zitat Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764CrossRefPubMed Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764CrossRefPubMed
2.
Zurück zum Zitat Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh Q-Y, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581CrossRefPubMed Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh Q-Y, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581CrossRefPubMed
3.
Zurück zum Zitat Bergenfelz AOJ, Wallin G, Jansson S, Eriksson H, Martensson H, Christiansen P, Reihner E (2012) Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg 396:83–90CrossRef Bergenfelz AOJ, Wallin G, Jansson S, Eriksson H, Martensson H, Christiansen P, Reihner E (2012) Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg 396:83–90CrossRef
4.
Zurück zum Zitat Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 19:2272–2278CrossRefPubMed Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 19:2272–2278CrossRefPubMed
5.
Zurück zum Zitat Hellman P, Ahlström H, Bergström M, Sundin A, Langström B, Westerberg G, Juhlin C, Akerström G, Rastad J (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981PubMed Hellman P, Ahlström H, Bergström M, Sundin A, Langström B, Westerberg G, Juhlin C, Akerström G, Rastad J (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981PubMed
6.
Zurück zum Zitat Sundin A, Johansson C, Hellman P, Bergström M, Ahlström H, Jacobson GB, Langström B, Rastad J (1996) PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770PubMed Sundin A, Johansson C, Hellman P, Bergström M, Ahlström H, Jacobson GB, Langström B, Rastad J (1996) PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770PubMed
7.
Zurück zum Zitat Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I (1998) [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 139:195–197CrossRefPubMed Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I (1998) [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 139:195–197CrossRefPubMed
8.
Zurück zum Zitat Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781. doi:10.1007/s00268-008-9537-5 CrossRefPubMed Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781. doi:10.​1007/​s00268-008-9537-5 CrossRefPubMed
9.
Zurück zum Zitat Tang B-N-T, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163CrossRefPubMed Tang B-N-T, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163CrossRefPubMed
10.
Zurück zum Zitat Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, Henne-Bruns D, Blagieva R, Böhm BO, Reske SN, Luster M (2010) C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res 42:209–214CrossRefPubMed Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, Henne-Bruns D, Blagieva R, Böhm BO, Reske SN, Luster M (2010) C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res 42:209–214CrossRefPubMed
11.
Zurück zum Zitat Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, Henne-Bruns D, Boehm BO, Reske SN, Luster M (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128CrossRefPubMed Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, Henne-Bruns D, Boehm BO, Reske SN, Luster M (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128CrossRefPubMed
12.
Zurück zum Zitat Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS (2013) Detection and Characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C—methionine PET/CT and (99 m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging 47:166–172CrossRefPubMedPubMedCentral Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS (2013) Detection and Characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C—methionine PET/CT and (99 m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging 47:166–172CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M (2014) 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT negative patients with primary hyperparathyroidism and previous neck surgery. JCEM 99:4199–4205PubMed Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M (2014) 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT negative patients with primary hyperparathyroidism and previous neck surgery. JCEM 99:4199–4205PubMed
14.
Zurück zum Zitat Bergenfelz AO, Jansson SK, Wallin GK, Martenson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicentre study comprising 2708 patients. Langenbecks Arch Surg 394:851–860CrossRefPubMed Bergenfelz AO, Jansson SK, Wallin GK, Martenson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicentre study comprising 2708 patients. Langenbecks Arch Surg 394:851–860CrossRefPubMed
16.
Zurück zum Zitat Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, Väisänen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Välimäki MJ (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747CrossRefPubMed Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, Väisänen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Välimäki MJ (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747CrossRefPubMed
17.
Zurück zum Zitat Schmidt M, Kahraman D, Neumaier B, Ortmann M, Stippel D (2011) Tc-99 m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-methionine PET/CT after previous thyroid surgery. Clin Nucl Med 36:1153–1155CrossRefPubMed Schmidt M, Kahraman D, Neumaier B, Ortmann M, Stippel D (2011) Tc-99 m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-methionine PET/CT after previous thyroid surgery. Clin Nucl Med 36:1153–1155CrossRefPubMed
Metadaten
Titel
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?
verfasst von
Theresia Weber
Martin Gottstein
Sabrina Schwenzer
Ambros Beer
Markus Luster
Publikationsdatum
10.11.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3795-4

Weitere Artikel der Ausgabe 4/2017

World Journal of Surgery 4/2017 Zur Ausgabe

Innovative Surgical Techniques Around the World

Completely Thoracoscopic Diaphragmatic Plication

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.